Welcome To The Critical Outcome Technologies Inc HUB On AGORACOM

Our disease Targets > Small cell lung cancer, Multiple sclerosis, HIV Integrase, Colorectal cancer & Adult acute leukemia

Free
Due Dilligence

COTI-2 Product Information

A nice update to COT's most advanced investigative cancer treatment.

Posted by: hoov on Feb 09, 2017 02:10PM
URL: http://criticaloutcome.com/wp-content/uploads/2017/01/COTI-2FactSheet.pdf

COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo

Preclinical trial laboratory assessment of COTI-2, an effective p53 cancer suppressor agent

Posted by: hoov on Nov 28, 2016 06:44PM
URL: http://www.impactjournals.com/oncotarget...op=view&path%5B%5D=9133&path%5B%5D=27861
Critical Outcome Technologies Inc Links

COTI-2 Product Information

A nice update to COT's most advanced investigative cancer treatment.

Posted by: hoov on Feb 09, 2017 02:10PM
URL: http://criticaloutcome.com/wp-content/uploads/2017/01/COTI-2FactSheet.pdf

COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo

Preclinical trial laboratory assessment of COTI-2, an effective p53 cancer suppressor agent

Posted by: hoov on Nov 28, 2016 06:44PM
URL: http://www.impactjournals.com/oncotarget...op=view&path%5B%5D=9133&path%5B%5D=27861